Status:
UNKNOWN
Effects of Vitamin D and Omega-3 Supplementation on Telomeres in VITAL
Lead Sponsor:
Augusta University
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Aging
Eligibility:
All Genders
50+ years
Phase:
PHASE3
Brief Summary
The VITamin D and OmegA-3 TriaL (VITAL; NCT 01169259) was a randomized clinical trial in 25,871 U.S. men and women investigating whether taking daily dietary supplements of vitamin D3 (2000 IU) or fis...
Detailed Description
This project is an ancillary study based on the parental study "the VITamin D and OmegA-3 TriaL (VITAL; NCT 01169259)" at the Harvard Clinical and Translational Science Centre (CTSC) and Brigham and W...
Eligibility Criteria
Inclusion
- The subcohort of 1,054 participants in VITAL (NCT 01169259) who are receiving detailed health assessments at a Clinical and Translation Science Center at Boston are eligible to participate in this ancillary study:
- \-
Exclusion
- None
- \-
Key Trial Info
Start Date :
August 19 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2021
Estimated Enrollment :
1054 Patients enrolled
Trial Details
Trial ID
NCT04386577
Start Date
August 19 2016
End Date
April 30 2021
Last Update
May 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Georgia Prevention Institute
Augusta, Georgia, United States, 30912